Results 161 to 170 of about 17,246 (259)
Barriers and facilitators to accessing urologic cancer treatment for people experiencing homelessness: a systematic review. [PDF]
Pfluger S +3 more
europepmc +1 more source
Objectives To evaluate whether longitudinal tumour‐informed circulating tumour DNA (ctDNA) testing identifies patients at increased risk of upstaging and recurrence in high‐risk non‐muscle‐invasive bladder cancer (NMIBC). Patients and Methods A cohort of 52 patients with high‐risk NMIBC underwent serial plasma ctDNA testing using a personalised tumour ...
Can Aydogdu +17 more
wiley +1 more source
Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC)
Objectives To provide a comprehensive analysis regarding outcomes of repeated screening and detection of low‐grade versus high‐grade cancer from the European Randomised Study of Screening for Prostate Cancer (ERSPC). Materials and Methods This study analysed men aged 55–69 years at random across the ERSPC trial centres except France.
Niko Pasanen +17 more
wiley +1 more source
Inappropriate medication use and associated factors in geriatric patients with hypertension and diabetes. [PDF]
Alsultan MM +6 more
europepmc +1 more source
Function drives 1‐year decision regret in radical prostatectomy: a multicentre prospective study
Objectives To identify contemporary drivers of postoperative decision regret 1 year after radical prostatectomy (RP). Patients and Methods In this prospective, multicentre study, patients undergoing robot‐assisted RP (RARP) or retropubic open RP (ORP) for localised prostate cancer at seven centres in Germany and Austria (2022–2024) completed ...
Christopher Hirtsiefer +14 more
wiley +1 more source
Editorial: Genomic discoveries and pharmaceutical development in urologic tumors - volume II. [PDF]
Li W, Meng J, Yang H, Zhang T, Yin L.
europepmc +1 more source
Symptom‐guided reduction of BCG dwell time: findings from the north‐REG randomized trial
Objectives To evaluate the impact of personalized dwell‐time (DT) reductions on symptom prevalence and systemic toxicities in patients undergoing Bacillus Calmette–Guérin (BCG) instillation for non‐muscle invasive bladder cancer (NMIBC). Methods Within a multinational randomized controlled trial (North‐REG Dwell Time Study [NCT04701151]), 225 patients ...
Lene Munk +15 more
wiley +1 more source
Enhancing surgical efficiency: predicting same-day cancellations in urologic procedures. [PDF]
Suarez PA +5 more
europepmc +1 more source

